Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-5 of 5 for your search:
Drug:
mitotane
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CO-ACT-001
, NCT00094497
2.
Phase III Study of Neoadjuvant and Adjuvant Cisplatin-Based Chemotherapy and/or Surgical Resection in Young Patients With Stage I-IV Adrenocortical Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 22 at diagnosis
Sponsor:
NCI
Protocol IDs:
COG-ARAR0332
, ARAR0332, NCT00304070
3.
Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
EudraCT 2007-007262-38
, NCT00777244
4.
Phase II Randomized Study of Mitotane With Versus Without Anti-IGF-1R Recombinant Monoclonal Antibody IMC-A12 in Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UCCRC-16402A
, 16402A, 8199, NCT00778817
5.
Evaluation of Side Effects of Mitotane
Phase:
No phase specified
Type:
Treatment
Status:
Approved-not yet active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
Wue-ACC-Mitotane
, NCT00568139
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute